MEOX2 and glioblastoma: The four metabolic genes whose repression is shared in both the BT273 and BT379 cell lines when MEOX2 is knocked down are all known to be induced by hypoxia and play a key role in the glycolytic pathway and have all been proposed as possible therapeutic targets for glioblastoma.